| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0022-1759(03)00189-3 |
| P698 | PubMed publication ID | 12957406 |
| P50 | author | Gavin Giovannoni | Q59162815 |
| P2093 | author name string | Green AJ | |
| Keir G | |||
| Thompson EJ | |||
| Petzold A | |||
| P2860 | cites work | The structure and organization of the human heavy neurofilament subunit (NF-H) and the gene encoding it | Q24296688 |
| Axonal transection in the lesions of multiple sclerosis | Q29615585 | ||
| Alzheimer disease tangles share immunological similarities with multiphosphorylation repeats in the two large neurofilament proteins | Q33652987 | ||
| A structural scaffolding of intermediate filaments in health and disease | Q34453208 | ||
| Axonal transport of neurofilaments in normal and disease states | Q34582316 | ||
| Neurotypy: regional individuality in rat brain detected by immunocytochemistry with monoclonal antibodies | Q36283618 | ||
| Neurofilament phosphorylation: a new look at regulation and function | Q36724402 | ||
| Monoclonal antibodies distinguish phosphorylated and nonphosphorylated forms of neurofilaments in situ | Q37690582 | ||
| Neurofilament protein in cerebrospinal fluid: a potential marker of activity in multiple sclerosis. | Q40864697 | ||
| Microglial apoptosis induced by chromogranin A is mediated by mitochondrial depolarisation and the permeability transition but not by cytochrome c release | Q40891035 | ||
| Beta-amyloid inhibits integrated mitochondrial respiration and key enzyme activities | Q43858152 | ||
| Phosphorylation of neurofilament H subunit as related to arrangement of neurofilaments. | Q48139650 | ||
| Proteolysis of filament proteins in glial and neuronal cells after in vivo stimulation of hippocampal NMDA receptors | Q48426839 | ||
| An immunoblot study of neurofilament degradation in situ and during calcium-activated proteolysis | Q48532180 | ||
| An optimal antigen retrieval method suitable for different antibodies on human brain tissue stored for several years in formaldehyde fixative | Q48730208 | ||
| Spinal cord trauma in man: studies of phosphorylated neurofilament and ubiquitin expression | Q48894433 | ||
| Neurofilament protein levels in CSF are increased in dementia. | Q53227032 | ||
| Quantitative analysis of neurofilament proteins in Alzheimer brain by enzyme linked immunosorbent assay system. | Q53338341 | ||
| Patients with Amyotrophic Lateral Sclerosis and Other Neurodegenerative Diseases Have Increased Levels of Neurofilament Protein in CSF | Q55952248 | ||
| Increased cerebrospinal fluid levels of neurofilament protein in progressive supranuclear palsy and multiple-system atrophy compared with Parkinson's disease | Q64922770 | ||
| A subpopulation of primate corticocortical neurons is distinguished by somatodendritic distribution of neurofilament protein | Q67686823 | ||
| Neurofilament antibodies and spiral ganglion neurons of the mammalian cochlea | Q67932229 | ||
| Varying degrees of phosphorylation determine microheterogeneity of the heavy neurofilament polypeptide (Nf-H) | Q68985726 | ||
| Phosphorylation protects neurofilaments against proteolysis | Q70166470 | ||
| Effect of peroxynitrite on the mitochondrial respiratory chain: differential susceptibility of neurones and astrocytes in primary culture | Q72169534 | ||
| Markers of nerve tissue injury in the cerebrospinal fluid in patients with lumbar disc herniation and sciatica | Q77382130 | ||
| P433 | issue | 1-2 | |
| P304 | page(s) | 179-190 | |
| P577 | publication date | 2003-07-01 | |
| P1433 | published in | Journal of Immunological Methods | Q15755939 |
| P1476 | title | A specific ELISA for measuring neurofilament heavy chain phosphoforms | |
| P478 | volume | 278 |
| Q43273265 | A novel biomarker for retinal degeneration: vitreous body neurofilament proteins. |
| Q33657708 | A panel of neuron-enriched proteins as markers for traumatic brain injury in humans |
| Q36863037 | A systematic review and meta-analysis of CSF neurofilament protein levels as biomarkers in dementia. |
| Q36479616 | ALS biomarkers for therapy development: State of the field and future directions |
| Q46727880 | Acute axonal damage predicts clinical outcome in patients with multiple sclerosis |
| Q48763817 | Amniotic fluid brain-specific proteins are biomarkers for spinal cord injury in experimental myelomeningocele |
| Q35485799 | Axonal damage accumulates in the progressive phase of multiple sclerosis: three year follow up study. |
| Q36142095 | Axonal damage and outcome in subarachnoid haemorrhage. |
| Q34220288 | Axonal damage in the making: neurofilament phosphorylation, proton mobility and magnetisation transfer in multiple sclerosis normal appearing white matter |
| Q36807376 | Biomarker evidence for mild central nervous system injury after surgically-induced circulation arrest |
| Q34078026 | Blood and CSF Biomarker Dynamics in Multiple Sclerosis: Implications for Data Interpretation |
| Q33313220 | CSF biomarkers for improved prognostic accuracy in acute CNS disease |
| Q48699278 | CSF neurofilament protein analysis in the differential diagnosis of ALS. |
| Q36227579 | CSF neurofilament proteins in the differential diagnosis of dementia |
| Q40243703 | CSF neurofilaments in frontotemporal dementia compared with early onset Alzheimer's disease and controls |
| Q37705196 | Cerebrospinal Fluid Levels of Phosphorylated Neurofilament Heavy as a Diagnostic Marker of Canine Degenerative Myelopathy. |
| Q43145621 | Cerebrospinal fluid ATP metabolites in multiple sclerosis |
| Q37408133 | Cerebrospinal fluid biomarkers in Guillain-Barré syndrome--where do we stand? |
| Q37206262 | Cerebrospinal fluid biomarkers of neurodegeneration in chronic neurological diseases |
| Q38339554 | Cerebrospinal fluid levels of brain specific proteins in optic neuritis |
| Q37299687 | Death receptor 6 (DR6) antagonist antibody is neuroprotective in the mouse SOD1G93A model of amyotrophic lateral sclerosis |
| Q61813293 | Diagnostic and Prognostic Performance of Neurofilaments in ALS |
| Q34577625 | Effects of repeated intrathecal triamcinolone-acetonide application on cerebrospinal fluid biomarkers of axonal damage and glial activity in multiple sclerosis patients. |
| Q39748242 | Elevated CSF neurofilament proteins predict brain atrophy: A 15-year follow-up study |
| Q51376386 | Elevated levels of S100B, tau and pNFH in cerebrospinal fluid are correlated with subtypes of Guillain-Barré syndrome. |
| Q42769499 | Evidence for acute neurotoxicity after chemotherapy |
| Q34538926 | In vivo monitoring of neuronal loss in traumatic brain injury: a microdialysis study. |
| Q35000781 | Increased neurofilament light chain blood levels in neurodegenerative neurological diseases |
| Q36376777 | Investigation of sex-specific effects of apolipoprotein E on severity of EAE and MS. |
| Q80565681 | Keratin 8 and 18 hyperphosphorylation is a marker of progression of human liver disease |
| Q42728560 | Longitudinal Assessment of Transorbital Sonography, Visual Acuity, and Biomarkers for Inflammation and Axonal Injury in Optic Neuritis |
| Q38154930 | Molecular biomarkers of neurodegeneration |
| Q57498761 | Multicenter validation of CSF neurofilaments as diagnostic biomarkers for ALS |
| Q46766236 | Neurofilament a biomarker of neurodegeneration in autoimmune encephalomyelitis |
| Q39628369 | Neurofilament heavy chain and heat shock protein 70 as markers of seizure-related brain injury. |
| Q39219451 | Neurofilament heavy chain as a marker of neuroaxonal pathology and prognosis in acute encephalitis |
| Q37265143 | Neurofilament light chain level is a weak risk factor for the development of MS. |
| Q38737766 | Neurofilament proteins as body fluid biomarkers of neurodegeneration in multiple sclerosis |
| Q36161527 | Neurofilaments as Biomarkers for Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-Analysis |
| Q33753792 | Neurofilaments as a plasma biomarker for ICU-acquired weakness: an observational pilot study |
| Q57588817 | Neurofilaments as biomarkers in neurological disorders |
| Q39103639 | Neurofilaments in CSF As Diagnostic Biomarkers in Motor Neuron Disease: A Meta-Analysis |
| Q90167116 | Neurofilaments in disease: what do we know? |
| Q36973566 | Phosphorylation and compactness of neurofilaments in multiple sclerosis: indicators of axonal pathology |
| Q28481340 | Plasma neurofilament heavy chain levels correlate to markers of late stage disease progression and treatment response in SOD1(G93A) mice that model ALS |
| Q34981166 | Progression in multiple sclerosis is associated with low endogenous NCAM. |
| Q38113164 | Review on intermediate filaments of the nervous system and their pathological alterations |
| Q83061537 | Rostrocaudal dynamics of CSF biomarkers |
| Q50984144 | Science is 1% inspiration and 99% biomarkers. |
| Q50953861 | Serial cerebrospinal fluid neurofilament heavy chain levels in severe Guillain-Barré syndrome. |
| Q36925772 | Serial soluble neurofilament heavy chain in plasma as a marker of brain injury after cardiac arrest |
| Q45284798 | Serum neurofilament light chain is a biomarker of human spinal cord injury severity and outcome |
| Q33999870 | Soluble beta-amyloid precursor protein is related to disease progression in amyotrophic lateral sclerosis |
| Q36500261 | The diagnostic and prognostic value of neurofilament heavy chain levels in immune-mediated optic neuropathies. |
| Q61810716 | The prognostic value of neurofilament levels in patients with sepsis-associated encephalopathy - A prospective, pilot observational study |
| Q34005484 | The use of serum glial fibrillary acidic protein measurements in the diagnosis of neuromyelitis optica spectrum optic neuritis |
| Q45350295 | The value of the serum neurofilament protein heavy chain as a biomarker for peri-operative brain injury after carotid endarterectomy |
| Q42647034 | Translational evidence for two distinct patterns of neuroaxonal injury in sepsis: a longitudinal, prospective translational study. |
| Q47276330 | Treatment response in relation to inflammatory and axonal surrogate marker in multiple sclerosis |
| Q46303787 | pNfH is a promising biomarker for ALS. |
Search more.